Health technology assessment of the addition of spinal muscular atrophy (SMA) to the National Newborn Bloodspot Screening Programme

O'Donnell H, Comber L, Carrigan M, Dillon S, Finnegan E, Harrington P, Jordan K, Larkin L, Maher A, O'Neill M, O'Shea M, Ryan M, Spillane D, Spillane S, Teljeur C
Record ID 32018005371
English
Authors' objectives: At the request of the National Screening Advisory Committee (NSAC), the Health Information and Quality Authority (HIQA) agreed to undertake a health technology assessment (HTA) of the addition of spinal muscular atrophy (SMA) to the National Newborn Bloodspot Screening Programme (NNBSP). The findings of this HTA were presented to the NSAC to inform its recommendation to the Minister for Health.
Details
Project Status: Completed
URL for project: https://www.hiqa.ie/reports-and-publications/health-technology-assessment/health-technology-assessment-addition-spinal
URL for protocol: https://www.hiqa.ie/sites/default/files/2023-07/Protocol%20HTA%20of%20the%20addition%20of%20SMA%20to%20the%20NNBSP.pdf
Year Published: 2023
URL for published report: https://www.hiqa.ie/sites/default/files/2023-11/Addition-of-SMA-to-NNBSP.pdf
Requestor: National Screening Advisory Committee (NSAC)
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Ireland
MeSH Terms
  • Neonatal Screening
  • Muscular Atrophy, Spinal
  • Spinal Muscular Atrophies of Childhood
  • Infant, Newborn
Keywords
  • Spinal Muscular Atrophy
  • Screening
Contact
Organisation Name: Health Information and Quality Authority (HIQA)
Contact Address: Health Information and Quality Authority, George's Court, George's Lane,Smithfield, Dublin 7. PH : + 353 (01) 814 7464
Contact Name: info@hiqa.ie
Contact Email: info@hiqa.ie
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.